pharmacies

Rite Aid’s plan to close more stores as part of its bankruptcy process raises concern about how that might hurt access to medicine and care.

It will likely take a few weeks before medical marijuana is available in pharmacies. After they submit applications, inspections will be required before approval is granted.

Drug and staffing shortages remain, and stores are dealing with a new vaccine and insurance coverage for COVID shots. Some have addressed challenges, but customers can expert slower service and lines.

Thousands of patients with autoimmune diseases who rely on Humira, with a list price of $6,600 a month, could get financial relief from new low-cost rivals. So far, the pharmacy benefit managers that control drug prices have not delivered on those savings.

To drive down costs, insurers are delivering high-priced infusion drugs via third-party pharmacies. Hospitals and clinics are trying to convince states to limit this practice, known as "white bagging."

Drug shortages continue as Florida health care experts navigate what some expect to be the new normal of pharmacy.

Drug-makers, pharmacies, and physicians blame pharmacy benefit managers for high drug prices. Florida has already taken action. Now, Congress is finally on board, too, but will it matter?

The governor moved quickly to sign a bill that will place restrictions on pharmacy benefit managers. The House and Senate unanimously passed the measure Tuesday.

The bill is ready to go to Gov. Ron DeSantis, who during his annual State of the State address in March called for making PBM changes.

The House Appropriations Committee on Friday approved a bill that would make a series of changes to regulate PBMs. The Senate unanimously passed its version on Wednesday.